Dan Peisert, Assertio president and CEO

From CRL to buy­out in five months: As­ser­tio to ac­quire Spec­trum in $248M stock deal

Spe­cial­ty phar­ma­ceu­ti­cals com­pa­ny As­ser­tio Hold­ings will buy Spec­trum Phar­ma­ceu­ti­cals in an all-stock deal for about $248 mil­lion, the com­pa­nies said Tues­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.